academic article

• Health phenome of Parkinson's patients reveals prominent mood-sleep cluster..  Research square.  2023
• Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment..  Frontiers in neurology.  -. 2023
• Mitochondrial haplogroups and cognitive progression in Parkinson's disease..  Brain : a journal of neurology.  146:42-49. 2023
• Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment..  Brain communications.  4:-. 2022
• Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI..  NPJ Parkinson's disease.  7:-. 2021
• Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease..  Nature genetics.  53:787-793. 2021
• GBA.  Neurology.  95:e685-e696. 2020
• Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study..  Journal of Parkinson's disease.  10:505-510. 2020
• Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease..  Nature neuroscience.  22:144-147. 2019
• Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease..  Nature neuroscience.  21:1482-1492. 2018
• β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease..  Science (New York, N.Y.).  357:891-898. 2017
• Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts..  The Lancet. Neurology.  16:620-629. 2017
• Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's..  Annals of neurology.  80:674-685. 2016
• Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients..  Annals of neurology.  80:355-67. 2016
• Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly..  Neurology.  87:920-6. 2016
• α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities..  Cellular and molecular neurobiology.  36:437-48. 2016
• Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease..  Brain : a journal of neurology.  138:2659-71. 2015
• Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study..  Neurology.  81:1531-7. 2013
• Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse..  Proceedings of the National Academy of Sciences of the United States of America.  108:17141-6. 2011
• Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study..  Movement disorders : official journal of the Movement Disorder Society.  26:2283-6. 2011